The purpose of this paper is to review the causes and describe the appearance of drug-
induced gingival overgrowth, so that dental hygienists are better prepared to manage such …

Drug-induced gingival overgrowth is an iatrogenic disease caused by the use of phenytoin,
cyclosporine, nifedipine, and other medications in the susceptible patient. The gingival …

The first documented case of drug-induced gingival enlargement was reported in 1939.
Since that time, specific medications have been associated with this condition. Although the …

Abstract Background/Aims: Drug‐induced gingival overgrowth remains a significant problem
for the periodontologist. Many patients medicated with the drugs implicated in this unwanted …

There are many types of gingival enlargements which vary according to the etiologic factors
and pathologic processes that produce them. The most common drug-induced gingival …

Objectives: Identify the types of drugs associated with gingival overgrowth. Review the
pathophysiology of drug-induced gingival overgrowth. Summarize the treatment and …

This review discusses the etiology and treatment of gingival hyperplasia. It cites evidence
that medications such as phenytoin, an anticonvulsant; cyclosporine, an …

Gingival enlargement is an increase in the size or inflammation of the gingiva. Gingival
overgrowth, hypertrophic gingivitis, gingival hyperplasia, or gingival hypertrophy is the other …

Clinically apparent enlargement of the papillary and marginal gingivae is a common finding
in otherwise healthy humans and other mammals. Swelling (" tumor") is one of the five …

Gingival overgrowth is associated with the chronic usage of phenytoin, cyclosporin and the
dihydropyridines. The pathogenesis of this unwanted effect is uncertain but appears to be …